![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Antibody-Drug Conjugates (ADCs)
Also called ADCs. They act in these three steps:
1. Bind selectively to the malignant cell's antibody.
2. Doing this allows to enter directly into the tumorous cell.
3. Release cytotoxic molecules that kill the malignant cell.
All HealthTree resources available anywhere, anytime
Download our App
Get the Latest Cutaneous T-Cell Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Download our App
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811